Back
Anheuser-Busch InBev SA/NV Vs. Novo Nordisk AS Industry Stock Comparison
Buy
62
BUDFF
Anheuser-Busch InBev SA/NV
Last Price:
$62.40
Seasonality Move:
0.87%
Sell
44
NONOF
Novo Nordisk AS
Last Price:
$79.48
Seasonality Move:
4.87%
Buy
62
Anheuser-Busch InBev SA/NV (BUDFF)
is a Buy
Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?
-
The current Anheuser-Busch InBev SA/NV [BUDFF] share price is $63.45. The Score for BUDFF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
BUDFF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $88.53. The Score for NONOF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NONOF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUDFF Stock Price Chart
What is Anheuser-Busch InBev SA/NV's stock price today?
-
The Anheuser-Busch InBev SA/NV share price today is $63.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BUDFF is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $88.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing buying pressure, which is a positive indicator for future bullish movement.
BUDFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.26 | Buy |
Relative Strength Index (14 RSI): | 89.76 | Buy |
Chaikin Money Flow: | 2776 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (49.68 - 59.28) | Buy |
Bollinger Bands (100): | (49.02 - 60.48) | Buy |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.95 | Buy |
Relative Strength Index (14 RSI): | 52.6 | Buy |
Chaikin Money Flow: | 64503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (82.22 - 89.58) | Buy |
Bollinger Bands (100): | (84.27 - 110.31) | Sell |
BUDFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61 | Buy |
20-day SMA: | 55.78 | Buy |
50-day SMA: | 51.65 | Buy |
200-day SMA: | 58.33 | Buy |
8-day EMA: | 60.62 | Buy |
20-day EMA: | 56.98 | Buy |
50-day EMA: | 54.23 | Buy |
200-day EMA: | 56.78 | Buy |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 89.16 | Sell |
20-day SMA: | 86.25 | Buy |
50-day SMA: | 85.24 | Buy |
200-day SMA: | 115.53 | Sell |
8-day EMA: | 88.62 | Sell |
20-day EMA: | 87.33 | Buy |
50-day EMA: | 89.21 | Sell |
200-day EMA: | 105.17 | Sell |
Anheuser-Busch InBev SA/NV Earnings Growth & BUDFF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Anheuser-Busch InBev SA/NV Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Feb 24 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
24 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |